New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
05:58 EDTAZN, WFMStocks with implied volatility below IV index mean; WFM AZN
Stocks with implied volatility below IV index mean; Whole Foods (WFM) 27, AstraZeneca (AZN) 21 according to iVolatility.
News For AZN;WFM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
11:45 EDTWFMWhole Foods calls active
Whole Foods October weekly 31.5 and 32 calls are active on total call volume of 19K contracts (2K puts). October weekly call option implied volatility is at 40, October is at 35, November is at 40; compared to its 52-week range of 17 to 43. Active call volume suggests traders taking positions for large near term price movement.
October 1, 2015
07:31 EDTAZNLeerink to hold a roundtable
Subscribe for More Information
September 30, 2015
08:02 EDTAZNAstraZeneca says SYMBICORT results published in journal
Subscribe for More Information
September 29, 2015
08:07 EDTAZNAstraZeneca says Brilinta 60-mg tablets now available in U.S. pharmacies
Subscribe for More Information
September 28, 2015
08:00 EDTWFMWhole Foods says to cut 1,500 jobs, or 1.6% of workforce, over 8 weeks
Whole Foods Market said in a regulatory filing that as part of its ongoing commitment to lower prices for its customers and invest in technology upgrades while improving its cost structure, the company will reduce a number of positions over the next eight weeks. The company estimates the net reduction to be approximately 1,500 jobs, which represents 1.6 percent of its workforce. It anticipates many of the reductions to be managed through natural attrition and expects a significant percentage of affected Team Members will find other jobs from the nearly 2,000 open positions across the company or via new jobs created from the more than 100 new stores in development.Whole Foods Market added over 9,000 new jobs in the past year and created nearly 35,000 over the past five years. "This is a very difficult decision, and we are committed to treating affected Team Members in a caring and respectful manner. We have offered them several options including transition pay, a generous severance, or the opportunity to apply for other jobs. In addition, we will pay these Team Members in full over the next eight weeks as they decide which option to choose." said Walter Robb, co-CEO of Whole Foods Market. "We believe this is an important step to evolve Whole Foods Market in a rapidly changing marketplace."
07:52 EDTAZNIIR Holdings to hold a conference
Subscribe for More Information
September 25, 2015
07:22 EDTAZNEuropean Society for Medical Oncology to hold a conference
Subscribe for More Information
September 22, 2015
08:02 EDTAZNAstraZeneca to present 33 abstracts from respiratory disease portfolio at ERS
Subscribe for More Information
07:43 EDTAZNDrug stocks could be hurt by focus on pricing, says Oppenheimer
Subscribe for More Information
07:17 EDTAZNAstraZeneca eyes crowd sourcing for better cancer drug cocktails, Reuters says
AstraZeneca's decision release preclinical data from over 50 of its medicines is "unprecedented" in scale and will speed up the hunt for tumor-fighting drug combinations, Reuters says. The company is aiming for a crowd sourcing initiative to help mix the future's cancer drug cocktails, the report says. Reference Link
06:19 EDTAZNClinton to roll out plan to rein in prescription drug costs, USA Today reports
Subscribe for More Information
September 21, 2015
14:28 EDTAZNTuring CEO says will not change Daraprim price despite criticism
Subscribe for More Information
11:24 EDTAZNHillary Clinton vows to take on 'outrageous' specialty drug pricing
Hillary Clinton, on the heels of a Wall Street Journal report detailing Turing Pharmaceuticals' price hike to $750 from $13.50 per pill of a drug called Daraprim which treats a life-threatening parasitic infection, vowed to lay out a plan tomorrow to take on what she calls "price gouging" of specialty drugs. The presidential nominee stated in a tweet, "Price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on." The iShares Nasdaq Biotechnology Index (IBB) moved lower following Clinton's tweet.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use